{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:56:55Z","timestamp":1775080615985,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.peptides.2004.01.003","type":"journal-article","created":{"date-parts":[[2004,2,11]],"date-time":"2004-02-11T10:12:47Z","timestamp":1076494367000},"page":"585-588","source":"Crossref","is-referenced-by-count":21,"title":["The bombesin\/gastrin releasing peptide receptor antagonist RC-3095 blocks apomorphine but not MK-801-induced stereotypy in mice"],"prefix":"10.1016","volume":"25","author":[{"given":"Carolina A","family":"Meller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Ant\u00f4nio P\u00eagas","family":"Henriques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"Schwartsmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Roesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2004.01.003_BIB1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0091-3057(00)00324-5","article-title":"NMDA antagonists block expression of sensitization of amphetamine-and apomorphine-induced stereotypy","volume":"67","author":"Battisti","year":"2000","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.peptides.2004.01.003_BIB2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0304-3835(01)00543-2","article-title":"Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist Cetrorelix","volume":"171","author":"Chatzistamou","year":"2001","journal-title":"Cancer Lett."},{"key":"10.1016\/j.peptides.2004.01.003_BIB3","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/0006-8993(88)90375-7","article-title":"Effects of bombesin and gastrin-releasing peptide on memory processing","volume":"460","author":"Flood","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2004.01.003_BIB4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0278-5846(85)90181-2","article-title":"Cerebrospinal fluid cholecystokinin, bombesin and somatostatin in schizophrenia and normals","volume":"9","author":"Gerner","year":"1985","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.peptides.2004.01.003_BIB5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00002826-199306000-00006","article-title":"Differentiation between MK-801- and apomorphine-induced stereotyped behaviors in mice","volume":"16","author":"Hitri","year":"1993","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.peptides.2004.01.003_BIB6","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/hmg\/6.8.1241","article-title":"Autism and multiple exostoses associated with an X;8 translocation occurring within the GRPR gene and 3\u2032 to the SDC2 gene","volume":"6","author":"Ishikawa-Brush","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.peptides.2004.01.003_BIB7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0028-3908(80)90181-1","article-title":"Grooming elicited by intracerebroventricular bombesin and eledoisin in the mouse","volume":"19","author":"Katz","year":"1980","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2004.01.003_BIB8","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0196-9781(90)90064-C","article-title":"Bombesin: potential integrative peptide for feeding and satiety","volume":"11","author":"McCoy","year":"1990","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.01.003_BIB9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0196-9781(86)90026-4","article-title":"Behavioral alterations induced by substance P, bombesin, and related peptides in mice","volume":"7","author":"Meisenberg","year":"1986","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.01.003_BIB10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0014-2999(90)94160-Y","article-title":"Effects of dopamine D1 and D2 receptor agonists and antagonists on bombesin-induced behaviors","volume":"191","author":"Merali","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.peptides.2004.01.003_BIB11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0893-133X(98)00053-0","article-title":"Decreased bombesin peptide response to cigarette smoking in schizophrenia","volume":"20","author":"Olincy","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.peptides.2004.01.003_BIB12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0278-5846(89)90150-4","article-title":"The effects of concurrent D-1 and D-2 dopamine receptor blockade with SCH 23390 and eticlopride, on bombesin-induced behaviours","volume":"13","author":"Piggins","year":"1989","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.peptides.2004.01.003_BIB13","first-page":"1035","article-title":"Inhibitory effect of bombesin receptor antagonist RC-3095 on the growth of human pancreatic cancer cells in vivo and in vitro","volume":"54","author":"Qin","year":"1994","journal-title":"Cancer Res."},{"key":"10.1016\/j.peptides.2004.01.003_BIB14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-8993(84)90700-5","article-title":"Behavioral and electrophysiological manifestations of bombesin: excessive grooming and elimination of sleep","volume":"321","author":"Rasler","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2004.01.003_BIB15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0301-0082(94)90039-6","article-title":"The psychology of perserverative and stereotyped behaviour","volume":"44","author":"Ridley","year":"1994","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.peptides.2004.01.003_BIB16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0196-9781(03)00179-7","article-title":"Intrahippocampal infusion of the bombesin\/gastrin-releasing peptide antagonist RC-3095 impairs inhibitory avoidance retention","volume":"24","author":"Roesler","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.01.003_BIB17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF02245171","article-title":"Modulation of MK-801 response by dopaminergic agents in mice","volume":"107","author":"Verma","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.peptides.2004.01.003_BIB18","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/sj.mp.4000387","article-title":"Bombesin, obesity, and social behavior","volume":"3","author":"Wada","year":"1998","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.peptides.2004.01.003_BIB19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0031-9384(99)00214-0","article-title":"Differential effects of social isolation upon body weight, food consumption, and responsiveness to novel and social environment in bombesin receptor subtype-3 (BRS-3) deficient mice","volume":"68","author":"Yamada","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.peptides.2004.01.003_BIB20","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.mp.4000974","article-title":"Role of bombesin (BN)-like peptides\/receptors in emotional behavior by comparison of three strains of BN-like peptide receptor knockout mice","volume":"7","author":"Yamada","year":"2002","journal-title":"Mol. Psychiatry"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978104000051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978104000051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T04:22:40Z","timestamp":1550204560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978104000051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0196978104000051"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2004.01.003","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}